newsfilter
← Latest News
Business Wire·

VBI Vaccines Provides an Update on its Restructuring Proceedings

VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring proceedings announced